fda warning letter glp-1 solution september 2025 The FDA sent a warning letter to the Telehealth Booms as Demand for
Description
One of the biggest concerns many patients have is the fear of regaining weight after stopping GLP-1 medications like Semaglutide or Tirzepatide
Benefits: Helps reduce stubborn fat, supports cardiovascular and immune health, promotes digestion, and contributes to long-term metabolic and weight management
Manage canker sores with diet, stress reduction, and oral care.
Help your clients navigate the growing use of GLP-1 and GIP medications with confidence and professionalism
